Cited by 192Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Neuronal Hypertrophy in Asymptomatic Alzheimer Disease

Open access

Iacono, Diego, O'Brien, Richard, Resnick, Susan M., Zonderman, Alan B., Pletnikova, Olga, Rudow, Gay, An, Yang, West, Mark J., Crain, Barbara, Troncoso, Juan C.·2008·Journal of Neuropathology & Experimental Neurology

DOI 10.1097/nen.0b013e3181772794PMC PMC2518071

Open this paper in CoChat — free account Open PDF

Abstract

The pathologic changes of Alzheimer disease (AD) evolve very gradually over decades before the disease becomes clinically manifest. Thus, it is not uncommon to find substantial numbers of Abeta plaques and neurofibrillary tangles in autopsy brains of older subjects with documented normal cognition, a state that we define as asymptomatic AD (ASYMAD). The goal of this study is to understand the morphometric substrate of ASYMAD subjects compared with mild cognitive impairment and definite AD cases. We used designed-based stereology to measure the volumes of neuronal cell bodies, nuclei, and nucleoli in 4 cerebral regions: anterior cingulate gyrus, posterior cingulate gyrus, primary visual cortex, and CA1 of hippocampus. We examined and compared autopsy brains from 4 groups (n = 15 each) of participants in the Baltimore Longitudinal Study of Aging: ASYMAD, mild cognitive impairment, AD, and age-matched controls. We found significant hypertrophy of the neuronal cell bodies, nuclei, and nucleoli of CA1 of hippocampus and anterior cingulate gyrus neurons in ASYMAD subjects compared with control and mild cognitive impairment cases. In the posterior cingulate gyrus and primary visual cortex, the hypertrophy was limited to the nuclei and nucleoli. The hypertrophy of cortical neurons and their nuclei and nucleoli in ASYMAD may represent an early reaction to the presence of neurotoxic Abeta or tau, or a compensatory mechanism that prevents the progression of the disease into dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/nen.0b013e3181772794

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Self-citation
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942

Show all 67 references

Research works printed but not linked: 3

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Third Edition-Revised (DSM-II-R) . Washington, DC: American Psychiatric Press, Inc., 1987
Luna G . AFIP Manual of Histologic Staining Techniques. 3rd ed. New York, NY: McGraw-Hill Publications, 1968
Lorente De Nó, 1933, Studies on the structure of the cerebral cortex, I. The area entorhinalis. J Psychol Neurol, 45, 381

Sorted by citations

Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661
An overview of APP processing enzymes and products.
Chow, V. W., Mattson, M. P., Wong, P. C., & Gleichmann, M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8104-z · Cited by 684
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease
Daulatzai, M. A. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 440
Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
Perez-Nievas, B. G., Stein, T. D., Tai, H.-C., Dols-Icardo, O., Scotton, T. C., Barroeta-Espar, I., Fernandez-Carballo, L., de Munain, E. L., Perez, J., Marquie, M., et al. (2013) · Brain · doi:10.1093/brain/awt171 · Cited by 387
Lipid peroxidation and neurodegenerative disease
Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 385
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD
Tramutola, A., Triplett, J. C., Di Domenico, F., Niedowicz, D. M., Murphy, M. P., Coccia, R., Perluigi, M., & Butterfield, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13037 · Cited by 347
Advances in the prevention of Alzheimer's disease and dementia
Solomon, A., Mangialasche, F., Richard, E., Andrieu, S., Bennett, D., Breteler, M. M. B., Fratiglioni, L., Hooshmand, B., Khachaturian, A. S., Schneider, L. S. S., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12178 · Cited by 330
Nucleolar Stress: hallmarks, sensing mechanism and diseases
Yang, K., Yang, J., & Yi, J. (2018) · Cell Stress · doi:10.15698/cst2018.06.139 · Cited by 302
Cerebral Blood Flow Measured by Arterial Spin Labeling MRI as a Preclinical Marker of Alzheimer's Disease
Wierenga, C. E., Hays, C. C., & Zlatar, Z. Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141467 · Cited by 229
Untitled work
Iacono (2009) · doi:10.1212/wnl.0b013e3181b01077 · Cited by 203
Self-citation
Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates
Guilarte, T. R. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00023 · Cited by 196
A Large, Cross-Sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly
Shimada, H., Makizako, H., Doi, T., Yoshida, D., Tsutsumimoto, K., Anan, Y., Uemura, K., Lee, S., Park, H., & Suzuki, T. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00069 · Cited by 200
Distinct cerebral perfusion patterns in FTLD and AD
Hu, W. T., Wang, Z., Lee, V., Trojanowski, J., Detre, J., & Grossman, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f11e35 · Cited by 189
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 171
Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease
Pietrzak, M., Rempala, G., Nelson, P. T., Zheng, J.-J., & Hetman, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022585 · Cited by 155
Is Alzheimer’s Disease Risk Modifiable?
Serrano‐Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad181028 · Cited by 169
Mitochondrial Function and Cell Size: An Allometric Relationship
Miettinen, T. P., & Björklund, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.02.006 · Cited by 151
Cognitive and social lifestyle: links with neuropathology and cognition in late life
Bennett, D. A., Arnold, S. E., Valenzuela, M., Brayne, C., & Schneider, J. A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1226-2 · Cited by 148
A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration
Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140
Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
Pagonabarraga, J., Corcuera‐Solano, I., Vives‐Gilabert, Y., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., Delfino, M., Kulisevsky, J., & Gómez‐Ansón, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054980 · Cited by 149
Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)
O'Brien, R. J., Resnick, S. M., Zonderman, A. B., Ferrucci, L., Crain, B. J., Pletnikova, O., Rudow, G., Iacono, D., Riudavets, M. A., Driscoll, I., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1179 · Cited by 137
Self-citation
Asymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
Driscoll, I., & Troncoso, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745348 · Cited by 130
Self-citation
Emerging roles of the neuronal nucleolus
Hetman, M., & Pietrzak, M. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.002 · Cited by 133
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease
Arnold, S. E., Louneva, N., Cao, K., Wang, L.-S., Han, L.-Y., Wolk, D. A., Negash, S., Leurgans, S. E., Schneider, J. A., Buchman, A. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.004 · Cited by 123
The relationship between the morphological subtypes of microglia and Alzheimer’s disease neuropathology
Paasila, P. J., Davies, D., Kril, J. J., Goldsbury, C. S., & Sutherland, G. T. (2019) · Brain Pathology · doi:10.1111/bpa.12717 · Cited by 120
Activity dependent LoNA regulates translation by coordinating rRNA transcription and methylation
Li, D., Zhang, J., Wang, M., Li, X., Gong, H., Tang, H., Chen, L., Wan, L., & Liu, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-04072-4 · Cited by 116
Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer’s Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures
Zhao, Y., Cong, L., & Lukiw, W. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00407 · Cited by 116
Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid ß-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas
Fortea, J., Sala‐Llonch, R., Bartrés‐Faz, D., Lladó, A., Solé‐Padullés, C., Bosch, B., Antonell, A., Olives, J., Sánchez‐Valle, R., Molinuevo, J. L., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.017 · Cited by 112
Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review
Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106
Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease
Pagonabarraga, J., Soriano‐Mas, C., Llebaria, G., López‐Solà, M., Pujol, J., & Kulisevsky, J. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.11.017 · Cited by 103
Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer’s disease neuropathology
Bjorklund, N. L., Reese, L. C., Sadagoparamanujam, V.-M., Ghirardi, V., Woltjer, R. L., & Taglialatela, G. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-23 · Cited by 98
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Gómez-Isla, T., & Frosch, M. P. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00642-9 · Cited by 96
Neuropathological approaches to cerebral aging and neuroplasticity
Jellinger, K. A., & Attems, J. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.1/kjellinger · Cited by 94
Preserved neurogenesis in non-demented individuals with AD neuropathology
Briley, D., Ghirardi, V., Woltjer, R. L., Renck, A., Zolochevska, O., Taglialatela, G., & Micci, M. (2016) · Scientific Reports · doi:10.1038/srep27812 · Cited by 91
How Parkinson's disease meets nucleolar stress
Parlato, R., & Liss, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.014 · Cited by 87
Resilient Brain Aging: Characterization of Discordance between Alzheimer’s Disease Pathology and Cognition
Negash, S., Wilson, R. S., Leurgans, S. E., Wolk, D. A., Schneider, J. S., Buchman, A. S., Bennett, D., & Arnold, S. E. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990157 · Cited by 88
Emerging Role of the Nucleolar Stress Response in Autophagy
Pfister, A. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00156 · Cited by 83
White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels
Molinuevo, J. L., Ripollés, P., Simó, M., Lladó, A., Olives, J., Balasa, M., Antonell, A., Rodríguez‐Fornells, A., & Rami, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.027 · Cited by 82
The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
de Vries, L. E., Huitinga, I., Kessels, H. W. H. G., Swaab, D. F., & Verhaagen, J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00719-7 · Cited by 85
Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects: Equivalent β-Amyloid and Tau Loads With Divergent Cognitive Outcomes
Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., An, Y., Pletnikova, O., Rudow, G., Crain, B., & Troncoso, J. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000052 · Cited by 73
Self-citation
Dietary Supplementation of Walnuts Improves Memory Deficits and Learning Skills in Transgenic Mouse Model of Alzheimer's Disease
Muthaiyah, B., Essa, M. M., Lee, M., Chauhan, V. P. S., Kaur, K., & Chauhan, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140675 · Cited by 72
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
Sojkova, J., Beason‐Held, L. L., Zhou, Y., An, Y., Kraut, M. A., Ye, W., Ferrucci, L., Mathis, C. A., Klunk, W. E., Wong, D. F., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051946 · Cited by 74
Self-citation
Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease
Vilaplana, E., Rodriguez‐Vieitez, E., Ferreira, D., Montal, V., Almkvist, O., Wall, A. E., Lleó, A., Westman, E., Graff, C., Fortea, J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009405 · Cited by 68
The hormesis principle of neuroplasticity and neuroprotection
Mattson, M. P., & Leak, R. K. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.022 · Cited by 77
Distinct Functional Activity of the Precuneus and Posterior Cingulate Cortex During Encoding in the Preclinical Stage of Alzheimer's Disease
Rami, L., Sala‐Llonch, R., Solé‐Padullés, C., Fortea, J., Olives, J., Lladó, A., Peña-Gómez, C., Balasa, M., Bosch, B., Antonell, A., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120223 · Cited by 68
Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline
Thomas, K. R., Osuna, J., Weigand, A. J., Edmonds, E. C., Clark, A. L., Holmqvist, S. L., Cota, I. H., Wierenga, C. E., Bondi, M. W., Bangen, K. J., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20935171 · Cited by 68
Diagnostic Value of microRNA for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Hu, Y.-B., Li, C., Song, N., Zou, Y., Chen, S.-D., Ren, R., & Wang, G. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00013 · Cited by 61
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers
Singh, A., Allen, D., Fracassi, A., Tumurbaatar, B., Natarajan, C., Scaduto, P., Woltjer, R., Kayed, R., Limon, A., Krishnan, B., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200716 · Cited by 56
Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T
Chiu, P.-W., Mak, H. K., Yau, K. K. W., Chan, Q., Chang, R. C., & Chu, L. (2013) · AGE · doi:10.1007/s11357-013-9545-8 · Cited by 53
Relationship between Cortical Thickness and Neuropsychological Performance in Normal Older Adults and Those with Mild Cognitive Impairment
Cheng, C. P.-W., Cheng, S., Tam, C. W.-C., Chan, W.-C., Chu, C. W., & LAM, L. C. W. (2018) · Aging and Disease · doi:10.14336/ad.2018.0125 · Cited by 54
Aging dependent effect of nuclear tau
Gil, L., Federico, C., Pinedo, F., Bruno, F., Poves, A. B. R., Montoya, J. J., Olazabal, I. M., Ferrer, I., & Saccone, S. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.030 · Cited by 50
A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis
Atwood, C., & Bowen, R. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143210 · Cited by 56
Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Zolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49
Is there a neuropathology difference between mild cognitive impairment and dementia?
Haroutunian, V. H., Hoffman, L. B., & Been, M. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/vharoutunian · Cited by 52
The rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition
Fleischman, D. A., Leurgans, S. E., Arfanakis, K., Arvanitakis, Z., Barnes, L. L., Boyle, P. A., Han, S. D., & Bennett, D. A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0622-7 · Cited by 49
Evidence for nucleolar dysfunction in Alzheimer’s disease
Nyhus, C., Pihl, M., Hyttel, P., & Hall, V. J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0104 · Cited by 44
Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
Salvadó, G., Shekari, M., Falcón, C., Operto, G., Milà‐Alomà, M., Sánchez‐Benavides, G., Cacciaglia, R., Arenaza‐Urquijo, E. M., Niñerola‐Baizán, A., Perissinotti, A., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac134 · Cited by 45
Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus
Thomas, T. C., Ogle, S. B., Rumney, B. M., May, H. G., Adelson, P. D., & Lifshitz, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.038 · Cited by 45
Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Kok, F. K., van Leerdam, S., & de Lange, E. C. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210607 · Cited by 46
Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging
Pezzoli, S., Giorgio, J., Martersteck, A., Dobyns, L., Harrison, T. M., & Jagust, W. J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13438 · Cited by 42
Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42
PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment
Pérez-González, M., Mendióroz, M., Badesso, S., Sucunza, D., Roldán, M., Espelosin, M., Ursúa, S., Luján, R., Cuadrado‐Tejedor, M., & García‐Osta, A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101818 · Cited by 46
Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00862-z · Cited by 42
Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults
Vogt, N. M., Hunt, J. F. V., Adluru, N., Ma, Y., Hulle, C. A. V., Dean, D., Kecskemeti, S., Chin, N. A., Carlsson, C. M., Asthana, S., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12364 · Cited by 42
The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer’s disease.
Badea, A., Kane, L., Anderson, R. J., Qi, Y., Foster, M., Cofer, G. P., Medvitz, N., Buckley, A. F., Badea, A. K., Wetsel, W. C., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.014 · Cited by 39
Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer’s Disease
Triplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 40
Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease
Grand’Maison, M., Zehntner, S. P., Ho, M., Hébert, F., Wood, A., Carbonell, F., Zijdenbos, A. P., Hamel, É., & Bedell, B. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.005 · Cited by 39
The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease
Atwood, C., & Bowen, R. L. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.06.021 · Cited by 38
Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice
Sos, K. E., Mayer, M. I., Takács, V. T., Major, A., Bardóczi, Z., Beres, B. M., Szeles, T., Saito, T., Saido, T. C., Mody, I., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233700 · Cited by 37
Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons
Palanca, A., Casafont, Í., Berciano, M. T., & Lafarga, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.016 · Cited by 37
Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome
Powers, B. E., Velázquez, R., Kelley, C. M., Ash, J. A., Strawderman, M. S., Alldred, M. J., Ginsberg, S. D., Mufson, E. J., & Strupp, B. J. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1164-y · Cited by 34
Salivary lactoferrin is associated with cortical amyloid-beta load, cortical integrity, and memory in aging
Reseco, L., Atienza, M., Fernandez-Alvarez, M., Carro, E., & Cantero, J. L. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00891-8 · Cited by 33
DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease
Kanungo, J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt167 · Cited by 35
Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons
Kiryk, A., Sowodniok, K., Kreiner, G., Parkitna, J. M. R., Soenmez, A., Górkiewicz, T., Bierhoff, H., Wawrzyniak, M., Janusz, A., Liss, B., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00207 · Cited by 35
The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study
Kuhn, T. P., Schonfeld, D., Sayegh, P., Arentoft, A., Jones, J. D., Hinkin, C. H., Bookheimer, S. Y., & Thames, A. D. (2016) · Human Brain Mapping · doi:10.1002/hbm.23436 · Cited by 33
Dosage effects of human ribosomal genes (rDNA) in health and disease
Porokhovnik, L. N., & Lyapunova, N. A. (2018) · Chromosome Research · doi:10.1007/s10577-018-9587-y · Cited by 34
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34
Central Adiposity and Cortical Thickness in Midlife
Kaur, S., Gonzales, M. M., Strasser, B., Pasha, E. P., McNeely, J., Tanaka, H., & Haley, A. P. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000202 · Cited by 34
Cellular enlargement - A new hallmark of aging?
Davies, D., van den Handel, K., Bharadwaj, S., & Lengefeld, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036602 · Cited by 32
White Matter Hyperintensities are Positively Associated with Cortical Thickness in Alzheimer's Disease
Jacobs, H. I. L., Clerx, L., Gronenschild, E. H. B. M., Aalten, P., & Verhey, F. R. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131232 · Cited by 35
Amyloid imaging and memory change for prediction of cognitive impairment
Resnick, S. M., & Sojkova, J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt62 · Cited by 33
Self-citation
Traumatic brain injury alters long-term hippocampal neuron morphology in juvenile, but not immature, rats
Casella, E. M., Thomas, T. C., Vanino, D., Fellows-Mayle, W. K., Lifshitz, J., Card, J. P., & Adelson, P. D. (2014) · Child s Nervous System · doi:10.1007/s00381-014-2446-z · Cited by 32
Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan
Iacono, D., & Feltis, G. C. (2019) · Aging · doi:10.18632/aging.101757 · Cited by 36
Self-citation
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease
Batzu, L., Westman, E., & Pereira, J. B. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.012 · Cited by 30
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats
Healy-Stoffel, M., Ahmad, S. O., Stanford, J. A., & Levant, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.033 · Cited by 29
Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer’s Disease: Implications from a Transgenic Mouse Model of the Disease
Baazaoui, N., Flory, M. J., & Iqbal, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160845 · Cited by 31
Nuclear dynamics and stress responses in Alzheimer’s disease
Iatrou, A., Clark, E. M., & Wang, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00489-6 · Cited by 31
Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models
Evsyukov, V., Domanskyi, A., Bierhoff, H., Gispert, S., Mustafa, R., Schlaudraff, F., Liss, B., & Parlato, R. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028092 · Cited by 27
Autonomic dysfunction in neurodegenerative disease
Mather, M. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00911-8 · Cited by 28
Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model
Nikolajsen, G. N., Jensen, M. S., & West, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.006 · Cited by 25
Self-citation
Editorial [Hot Topic: The Complex and Multifactorial Nature of Alzheimers Disease (Guest Editors: Karim Alkadhi and Jason Eriksen)]
Alkadhi, K. A., & Eriksen, J. L. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376235 · Cited by 24
Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease
Jury-Garfe, N., Redding-Ochoa, J., You, Y., Martínez, P., Karahan, H., Chimal-Juárez, E., Johnson, T. S., Zhang, J., Resnick, S., Kim, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02775-1 · Cited by 22
“These individuals have neuritic plaque and NFTs Braak stages at autopsy comparable to those of AD subjects with dementia, and the literature refers to them as resilient [31], Nondemented with AD Neuropathology (NDAN) [83], or asymptomatic AD (AsymAD) [22, 42].”
BackgroundSelf-citation
Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat
Healy-Stoffel, M., Ahmad, S. O., Stanford, J. A., & Levant, B. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.045 · Cited by 24
Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults
Nosheny, R. L., Insel, P. S., Mattsson, N., Tosun, D., Buckley, S. T., Truran, D., Schuff, N. W., Aisen, P. S. S., & Weiner, M. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.005 · Cited by 23
Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects
Schreiner, S. J., Liu, X., Gietl, A. F., Wyss, M., Steininger, S. C., Gruber, E., Treyer, V., Meier, I. B., Kälin, A. M., Leh, S. E., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00240 · Cited by 21
Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease
Badea, A., Delpratt, N. A., Anderson, R. J., Dibb, R., Qi, Y. P., Wei, H., Liu, C., Wetsel, W. C., Avants, B., & Colton, C. A. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.03.022 · Cited by 23
Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment
Regier, M., Liang, J., Choi, A. H., Verma, K. C., Libien, J. M., & Hernandez, A. I. (2019) · Neural Plasticity · doi:10.1155/2019/4383258 · Cited by 22

Authors: Iacono, D., O'Brien, R., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Rudow, G., An, Y., West, M. J., Crain, B., & Troncoso, J. C.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
Aarhus University (DK)
Corresponding author: Troncoso, Juan C.
ORCID: Iacono, Diego
Resnick, Susan M.
Zonderman, Alan B.
An, Yang
West, Mark J.
Troncoso, Juan C.
Venue: Journal of Neuropathology & Experimental Neurology
Publisher: Oxford University Press (OUP)
Published: 2008-06
Volume: 67
Issue: 6
Pages: 578-589
ISSN: 0022-3069 (ISSN-L)
1554-6578
DOI: 10.1097/nen.0b013e3181772794
PMC: PMC2518071
OpenAlex: W2097399504
Cited by: 188
References: 67
Citations by year: 2026: 6 · 2025: 16 · 2024: 15 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 6 · 2019: 14 · 2018: 8 · 2017: 8 · 2016: 11 · 2015: 10 · 2014: 13 · 2013: 17 · 2012: 8
FWCI: 6.09
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neuropathology & Experimental Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Burroughs Wellcome Fund
Johns Hopkins University
National Institutes of Health
National Institute on Aging (K23AG034550, Z01AG000191, P50AG005146, AG 05146)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: neuronal hypertrophy, hippocampal CA1, anterior cingulate cortex, posterior cingulate cortex, primary visual cortex, mild cognitive impairment, amyloid plaques, neurofibrillary tangles, stereology
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cognition Disorders, Humans, Hypertrophy, Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuronal Hypertrophy in Asymptomatic Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks